uracil has been researched along with Glial Cell Tumors in 7 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| "The synthesis and molecular and supramolecular structures of the compound (6-amino-1-methyl-5-nitrosouracilato-N3)-triphenylphosphine-gold(I) with interesting abilities to inhibit tumor growth in an animal model of experimental glioma are reported." | 7.79 | A potential antitumor agent, (6-amino-1-methyl-5-nitrosouracilato-N3)-triphenylphosphine-gold(I): structural studies and in vivo biological effects against experimental glioma. ( García-García, AR; Illán-Cabeza, NA; Martínez-Martos, JM; Moreno-Carretero, MN; Peña-Ruiz, T; Ramírez-Expósito, MJ, 2013) |
| "The synthesis and molecular and supramolecular structures of the compound (6-amino-1-methyl-5-nitrosouracilato-N3)-triphenylphosphine-gold(I) with interesting abilities to inhibit tumor growth in an animal model of experimental glioma are reported." | 3.79 | A potential antitumor agent, (6-amino-1-methyl-5-nitrosouracilato-N3)-triphenylphosphine-gold(I): structural studies and in vivo biological effects against experimental glioma. ( García-García, AR; Illán-Cabeza, NA; Martínez-Martos, JM; Moreno-Carretero, MN; Peña-Ruiz, T; Ramírez-Expósito, MJ, 2013) |
| "5." | 1.32 | Extracellular metabolism of nucleotides in neuroblastoma x glioma NG108-15 cells determined by capillary electrophoresis. ( Kaulich, M; Müller, CE; Qurishi, R, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Illán-Cabeza, NA | 2 |
| Jiménez-Pulido, SB | 1 |
| Hueso-Ureña, F | 1 |
| Ramírez-Expósito, MJ | 2 |
| Martínez-Martos, JM | 2 |
| Moreno-Carretero, MN | 2 |
| García-García, AR | 1 |
| Peña-Ruiz, T | 1 |
| Kaulich, M | 1 |
| Qurishi, R | 1 |
| Müller, CE | 1 |
| Harada, K | 1 |
| Okamoto, H | 1 |
| Kiya, K | 1 |
| Fujioka, Y | 1 |
| Uozumi, T | 1 |
| Kodama, Y | 1 |
| Gehan, EA | 1 |
| Wakisaka, S | 2 |
| Shimauchi, M | 2 |
| Kaji, Y | 2 |
| Nonaka, A | 2 |
| Kinoshita, K | 2 |
| Maruoka, N | 1 |
| Moriyama, T | 1 |
| Oyama, H | 1 |
| Goya, T | 1 |
| Kodama, T | 1 |
7 other studies available for uracil and Glial Cell Tumors
| Article | Year |
|---|---|
Relationship between the antiproliferative properties of Cu(II) complexes with the Schiff base derived from pyridine-2-carboxaldehyde and 5,6-diamino-1,3-dimethyluracil and the redox status mediated by antioxidant defense systems on glioma tumoral cells.
Topics: Aldehydes; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Cycle Checkpoints; Cell Lin | 2020 |
A potential antitumor agent, (6-amino-1-methyl-5-nitrosouracilato-N3)-triphenylphosphine-gold(I): structural studies and in vivo biological effects against experimental glioma.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cell Proliferation; Crystallography, X-Ray; Dose-Respo | 2013 |
Extracellular metabolism of nucleotides in neuroblastoma x glioma NG108-15 cells determined by capillary electrophoresis.
Topics: Adenosine; Alkaline Phosphatase; Animals; Chromatography, Micellar Electrokinetic Capillary; Dipyrid | 2003 |
[Pharmacokinetics study of UFT in malignant brain tumor patients].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; | 1983 |
Design of controlled clinical trials: use of historical controls.
Topics: Acute Disease; Adolescent; Adult; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubic | 1982 |
Acute phenytoin intoxication associated with the antineoplastic agent UFT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; D | 1990 |
[AUFRAP therapy: combined modality treatment of malignant gliomas with intraarterial infusion of ACNU].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carotid Artery, Internal; Co | 1988 |